Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
Brown, S Hutchinson, C Aspinall-O'Dea, M Whetton, A Johnson, Suzanne M Rees-Unwin, K Burthem, J
Brown, S
Hutchinson, C
Aspinall-O'Dea, M
Whetton, A
Johnson, Suzanne M
Rees-Unwin, K
Burthem, J
Citations
Altmetric:
Abstract
Mature dendritic cells (DCs) may be derived from the BCR/ABL1 expressing monocytes in chronic myeloid leukaemia. These cells have potential therapeutic applications, but are recognised to have defective function. In normal DCs, activation and maturation depend on ABL1 dependent signals. We therefore tested the hypothesis that in the DCs of chronic myeloid leukaemia, the presence of the BCR/ABL1 molecule disrupts normal ABL1 signal pathways, and contributes to the observed functional defects of the cells.
Description
Date
2014-08
Publisher
Collections
Keywords
Type
Article
Citation
Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein. 2014, 93 (2):96-102 Eur J Haematol